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Abstract
Background
Hookworm is a soil-transmitted nematode (STN) infection associated with rural poverty that
infects 576-740 million people worldwide, 200 million of which reside in Sub-Saharan
Africa. In 2001, the WHO passed a resolution that recommended annual deworming for
school-aged children where the prevalence of STNs is higher than 20%. Since this time,
albendazole has been widely used across sub-Saharan Africa to treat hookworm infection.
Given the widespread use of albendazole as a treatment for hookworms and other STNs in
humans, it becomes pertinent to ensure that resistance is monitored at the local level, and
detected as it emerges. Previous research in Kintampo, Ghana found a high prevalence of low
intensity hookworm infection prior to treatment, and raised concerns about emerging
resistance to albendazole.
Methods
Children between the ages of 7-12 from four villages were enrolled in this study and given a
questionnaire to gather demographic and health information about each participant (n=178).
Fecal containers were distributed to enrolled children and the Kato-Katz technique was used
to identify a positive infection and to estimate the severity of the infection. Children that were
infected with hookworm were treated with a single dose of 400mg albendazole, and a second
stool sample was collected from these children at 10-14 days post-treatment. Kato-Katz
methods, Egg Extraction, EHA, and the Baermann method were conducted on all positive
samples pre- and post-treatment. Genomic DNA was extracted from frozen purified
hookworm eggs and larvae from pre- and post-treatment samples and stored for future
testing. Molecular methods were utilized to identify the hookworm species in each sample
Results
At baseline, 57/178 (32.0%) of children from four villages were positive for hookworm. The
highest prevalence was seen in Jato (43.7%), while the lowest prevalence was observed in
Tahiru (8.0%). Post-treatment, 36.8% (21/57) of children infected at baseline were still
hookworm positive. All of the children from Cheranda and Tahiru were cleared of infection,
while in Mahama, one child harbored a light infection (CR=80%, FECR=97.9%). In Jato the
cure rate was low (55.5%) and the Fecal Egg Count Reduction rate (FECR) was suboptimal
(87.9%). Pre-treatment, almost all children harbored light infections, while all children were
lightly infected post-treatment.
Discussion
These data demonstrate the need for more targeted approaches to the treatment of helminth
infections, as variable responses are observed within each community. Findings from Jato
suggest that in some communities, therapeutic intervention alone is not enough. Control
measures such as health education or providing access to latrines could make a more
substantial impact in communities like Jato, where MDA has been implemented, and where
infection rates continue to be high among school-aged children. Data from this study further
support the need for new approaches to combat the disease burden posed by helminth
infections in much of the developing world.
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I.

Introduction
a. A Brief History of Hookworm Disease
Today a disease of rural poverty, hookworm infection has been observed in humans for

over 5,000 years (Cox 2002). The earliest written record of hookworm infection is commonly
ascribed to the Ebers papyrus of 1500 B.C., when an anemia like condition that caused pallor
and laziness was described (Cox 2002). Records from 300 B.C. depict hookworm infection
as a disease that is characterized by intestinal distress and a tendency to eat dirt (Power
2001). Similar descriptions of a disease associated with pallor and weakness appear in the
writing of Lucretius in 50 B.C., and in references from China in the third century(Cox 2002).
An increasing number of references to the suspected disease appeared in records from
European explorers in the West Indies and South and Central America in the 18th-19th
centuries (Cox 2002).
Italian physician Angelo Dubini first identified one species of hookworm, Ancylostoma
duodenale, in 1838, where he observed that it used its teeth to attach to the intestinal lining
(Power 2001). Building off his work, Wilhelm Griesinger drew a connection between the
worms and iron deficiency anemia during autopsies in 1854 (Cox 2002). While examining
feces with microscopy in 1878, Giovanni B. Grassi developed the first diagnostic method for
examining hookworm ova, and the first anthelminthic drug, thymol, was developed shortly
thereafter (Power 2001). Just two years later, Edoardo Perroncito correlated an anemia
outbreak among miners in the St. Gothard tunnel with hookworm infection, after noting in
autopsies that a high number of hookworms correlated with the symptoms of anemia (Power
2001). Finally, in the early 20th century, a second species of hookworm, Necator americanus
was identified among agricultural laborers in Puerto Rico. Shortly thereafter, Arthur Loos
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discovered how hookworms enter the body and reach the small intestine after accidently
infecting himself (Power 2001, Cox 2002).

b. Hookworm Biology and Disease Pathology
Human hookworm infection is a parasitic disease caused by two types of blood sucking,
soil-transmitted nematodes (STNs): Ancylostoma duodenale and Necator americanus (Hotez
P. 2005). Symptoms of infection vary, and typically begin with itching and a localized rash
that results when larvae penetrate the skin. Although most infections with hookworm are
asymptomatic (especially light infections), symptoms may include abdominal discomfort,
fatigue, weight loss, anemia and protein deficiencies. Heavy infection can result in the
impairment of physical and cognitive development, especially among children, who can lose
up to 20mls of blood each day as a result of infection (Humphries D 2012, Bird, Ame et al.
2014).
Although infection with hookworm is rarely fatal, it can often increase susceptibility to
other STNs such as trichuriasis, and diseases such as malaria, HIV and tuberculosis
(Humphries D 2013). The impact of hookworm infection on the host, and the level of anemia
that results are typically dependent on a variety of factors. The worm burden plays a role in
influencing the severity of disease, as does the hosts’ nutritional status. Iron reserves and diet
play a key role in the severity of disease, making the infection more detrimental among
children that are malnourished. The species of hookworm also plays a role in the severity of
disease, due to the fact that A. duodenale typically causes more blood loss than N.
americanus (Brooker S 2004).
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c. Hookworm Lifecycle
When hookworm eggs are passed in the stool, under certain conditions (such as shade,
moisture and warmth) the eggs will hatch over a period of 1 to 2 days ((CDC) 2013). Over a
period of 5-10 days, the hatched larvae undergo two molts, after which time they become
infectious filariform third-stage larvae (L3) ((CDC) 2013).Under the right environmental
conditions, these larvae can live in the soil for as long as 4 weeks ((CDC) 2013).
Figure 1: Life Cycle of Human Hookworms

Humans typically become infected with hookworm when skin comes into contact with L3
larvae in the soil, although A. duodenale L3 have been shown to infect by both the skin and
oral route (Hotez P 2004). Following host entry, L3 are carried by blood vessels to the heart
and then on to the lungs over a period of approximately ten days ((CDC) 2013). L3 enter the
digestive system by penetrating the pulmonary alveoli and ascending to the trachea, where
they are coughed up and swallowed (Hotez P. 2005, Bungiro R 2011). Upon entering the
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gastrointestinal tract, hookworms undergo two molts, after which time they reach the adult
blood feeding stage (Hotez P 2004). After using their teeth to attach to the intestinal mucosa
in the lumen of the small intestine, they begin feeding on tissue and blood (Hotez P. 2005,
Bungiro R 2011). Once adhered to the small intestine, adult hookworms mate and begin
producing eggs, which are then excreted in the feces (Hotez P. 2005, Bungiro R 2011).
Following excretion, the hookworm eggs in the stool are released into the environment, and
can thereby repeat the parent life cycle (Hotez P. 2005, Bungiro R 2011) (Figure 1).

d. Epidemiology of Hookworm Infection
Although hookworm infection has been eliminated from more developed nations,
infection is still highly prevalent in many parts of the developing world, especially among
school-aged children (SAC). It has been estimated that there are still an estimated 740
million people infected with hookworm around the world, with more disability adjusted life
years (DALYs) lost than any other helminth infection except lymphatic filariasis (Hotez P
2006). Higher prevalences of disease are observed in tropics and subtropics, and highest in
rural areas (Brooker S 2004). Although it is more common to see the highest intensities of
STN infections among children, both children and adults are frequently heavily infected
with hookworm (Hotez P. 2005).
Infection with N. americanus has been shown to be more widespread, while infection
with A. duodenale has been shown to be more focalized (Hotez P. 2005). Infection with N.
americanus is seen throughout the world, in regions such as South and Southwest China,
Southeast asia, Southern India, sub-Saharan Africa, and South and Central America
(Brooker S 2004). In contrast, A. duodenale is predominantly found in regions with harsher
environmental conditions, where it is less likely for N. americanus to survive (Brooker S
2004). These regions include the northern parts of southern India, southern and western
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China, and a few parts of Latin America (Northern Argentina, Paraguay) and Northern
Australia (Hotez P. 2005).
Figure 2: Global Distribution of Human Hookworm Infection

Hotez PJ, Bethony J, Bottazzi ME, Brooker S, et al. (2005) Hookworm: “The Great Infection of
Mankind”. PLoS Med 2(3): e67.

While hookworm infection can be found in much of the developing world, rates vary
by region (Figure 2). Central and South America see the lowest prevalence of disease (10%),
followed by China and south Asia (16%) and southeast Asia (26%) (Humphries D 2012). The
highest prevalence and intensity of infections are observed in Sub-Saharan Africa (29%),
where there are an estimated 200 million cases (Brooker S 2004, Humphries D 2011). While
improvements in socioeconomic status, water, sanitation, and control efforts have decreased
the disease burden in other parts of the world such as Latin America, there has been little
change in the prevalence of hookworm in Sub-Saharan Africa (Brooker S 2004). In Ghana,
some regions see a prevalence of infection that exceeds 87.5%, while rates of infection
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among school aged children in Kintampo have been reported to be around 45% (Ziem J 2006,
Humphries D 2011).

e. Risk Factors for Infection
Hookworm infection transmission is dependent upon environmental contamination
with hookworm eggs. As such, infection with hookworm is often influenced by
socioeconomic status. Limited access to clean water, sanitation and adequate health care,
along with poor education provide an environment under which transmission can continue
(Hotez P 2004). Working in agriculture, a common occupation in much of the developing
world, has been shown to be associated with infection, especially in areas where waste water
or night soil is regularly used to enhance agricultural production (de Silva 2003). Inadequate
hygiene practices and the absence of latrines and sewage treatment have also been shown to
be associated with infection (Raso, Vounatsou et al. 2006). Not wearing shoes is also
associated with elevated rates of infection, and poor nutritional status, malaria, and anemia
prior to infection are known to exacerbate the effects of the disease (Hotez P 2004).

f. Disease Treatment and Management: Efficacy of Benzimidazoles and Secondary
Drugs
The main class of drugs used to treat soil-transmitted helminthes, including
hookworm infections, is the benzimidazoles. These drugs bind to the tubulin protein of
microtubules, which are important organelles involved in cell motility and division (Keiser J
2010). By binding to these organelles, the uptake of glucose is blocked, which ultimately
empties glycogen reserves in the parasite (J 2002). Depleted of energy, the worm is then
expelled from its host, or is paralyzed and dies (J 2002). Although lethal to the parasite, these
drugs are generally well tolerated by the host (J 2002). This is because they have a higher
affinity for binding to tubulin in the worm than in humans or livestock (J 2002). Although
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considerably effective at treating many types of worm infections, these drugs are quickly
excreted from the body and do not provide any protection against reinfection (J 2000).
Albendazole, a drug in the class of benzimidazoles, is the primary drug
recommended for the treatment of hookworm infection. Approved for human use in 1987,
albendazole is administered orally and can be used to treat a variety of worm infections,
including ascariasis, trichuriasis, enterobiasis and hookworm (Keiser J 2010). In a recent
review conducted by Keiser and Utzinger, 11 different studies showed that albendazole
therapy was well tolerated, and that there were no significant adverse events reported
following albendazole administration (Keiser J 2008). However, mild symptoms including
dizziness, headache, nausea, vomiting, and abdominal pain have been reported in response to
treatment with a single dose of albendazole (Keiser J 2010).
Mebendazole is another benzimidazole that can be used to treat hookworm infection,
although the drug is not as effective at treating hookworm as albendazole (Keiser J 2010).
Like many other benzimidazoles, mebendazole is administered in a single dose and targets
the tubulin in the parasite cell (Keiser and Utzinger 2008). Although mebendazole is less
effective in the treatment of hookworm infection, it has a high efficacy in the treatment of
Ascaris (Keiser and Utzinger 2008).
Pyrantel pamoate acts as a nicotinic acetylcholine receptor antagonist in the parasite
(Keiser J 2010). By doing so, it causes spastic paralysis of the worm, ultimately leading to
death.(Keiser J 2010) Although it is a second line drug for hookworm, pyrantel pamoate is
more commonly used in the treatment of ascariasis and enterobiasis, with cure rates of 90100% (Keiser and Utzinger 2008). In a review examining its efficacy in treating hookworm
infection, nearly half of patients in one trial experienced adverse events such as nausea,
dizziness and abdominal pain (Keiser and Utzinger 2008). Similar to pyrantel pamoate,
levamisole targets the acetylcholine receptor within the parasite, ultimately leading to the
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paralysis and death of the worm. Levamisole is associated with a diverse array of side effects
including vomiting, diarrhea, dizziness, and headache (Mehlorn 2008). Given the higher risk
of adverse events, these drugs are recommended only as second line drugs for the treatment
of hookworm infection (Keiser and Utzinger 2008).

g. An Assessment of Drug Efficacy and the Treatment of Hookworm Infection
When examining the efficacy of these drugs against hookworm in 20 randomized
controlled trials, a single dose of 400 mg albendazole was found to have an overall cure rate
of 72%, while mebendazole had a cure rate of 15% and pyrantel had a cure rate of 32%
(Keiser J 2008). Levamisole treatment in several trials had cure rates between 10%-38%
(Keiser J 2008). This study went on to conclude that, when administered as a single-dose
therapy, albendazole reduced the prevalence of hookworm more effectively than any other
drug (Keiser J 2008). Although albendazole is the primary therapy used to treat hookworm
infection, pyrantel pamoate and levamisole are considered to be alternative treatments for
hookworm (Keiser J 2008). Despite the low cure rate for mebendazole therapy, it is still
widely used to treat hookworm (Keiser J 2008). In Ghana, between 4-5 million children are
still treated with mebendazole therapy each year, despite its low cure rate (Keiser J 2008).
There have been several studies that have examined the decreasing susceptibility of
parasitic worms to anthelmintic drugs in livestock. A recent study conducted in Uganda
observed very low efficacy for albendazole therapy (28.5%) when treating goats for
gastrointestinal nemotodes (Byaruhanga C 2013). Another study conducted in Northern
Ireland examined treatment efficacy for several benzimidazoles used to treat flocks of sheep,
and found significant resistance to one or more of these drugs in 81% of blocks tested
(McMahon C 2013). In a 2010 study, Vercruysse points out that many years of using
anthelminthic drugs to control roundworms in livestock resulted in high levels of resistance
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to the drugs (Vercruysse J 2011). Later, he mentions that treatment frequency and possible
under-dosing have been identified as contributors to the development of drug resistance
(Vercruysse J 2011).
Although albendazole therapy has become the standard course of treatment for
hookworm infection in humans, there have been reports that have brought up the possibility
of a decreasing susceptibility to the drug. A study conducted in Laos in 2010 noted that
albendazole therapy had a cure rate of 36%, far less than the cure rate seen in the majority of
studies (Soukhathammavong P 2012). While they concluded that differences in hookworm
species susceptibilities, host factors, and co-infection with other STNs could play a role in
treatment failure, the possibility of increasing resistance to albendazole could not be ruled out
(Soukhathammavong P 2012). Two trials conducted in Vietnam in 2007 found that singledose albendazole was no more effective against hookworm than a placebo, and noted that
only a three-dose regimen of albendazole was more effective at treating hookworm than the
placebo (Flohr C 2007).

h. Strategies for the Control of Disease Burden
At the turn of the 20th century, hookworm disease, commonly referred to as a “disease
of laziness” was widespread across the southern United States (Bleakley 2007). After
realizing the serious public health problem that hookworm disease posed in this region, the
Rockefeller Foundation founded the Rockefeller Sanitary Commission (RSC) for the
eradication of hookworm disease, and initiated a campaign from 1910-1915 (Brooker S 2004,
Bleakley 2007). This campaign used a multifaceted approach to decrease the burden of the
disease, involving treatment, education, and latrine building across the southern United States
(Bleakley 2007). At the start of the campaign, the RSC surveyed over 600 counties across the
south and found that the prevalence of disease among school aged children in the American
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South averaged 43% (Bleakley 2007, M 2009). Following this observation, the RSC built
latrines and created traveling treatment dispensaries that provided thymol to nearly 400,000
individuals over the course of the campaign (Power 2001, Bleakley 2007, M 2009). At the
same time, the RSC initiated an educational campaign to inform both the public and local
physicians about hygiene practices and how to recognize and prevent infection (Bleakley
2007). Although these strategies failed to eliminate hookworm disease from the southern
United States, this multifaceted approach resulted in a 50% decrease in the prevalence of the
disease (Bleakley 2007). As the RSC’s campaign came to a close, local and state
governments began to fund anti-hookworm campaigns, and took over many of the
foundations activities (Bleakley 2007, M 2009). As result of this campaign and the growing
awareness that ensued, hookworm disease experienced a significant decline in the southern
United States that ultimately led to its elimination from the region (M 2009).
Although hookworm infection still exists in much of the developing world, this
campaign demonstrated that a combination of education, infrastructure development and
therapy can make a significant difference in the prevalence of hookworm infection.
In an attempt to alleviate the disease burden in the developing world, the World Health
Organization passed a resolution in 2001 at the 54th World Health Assembly to control
infection (Humphries D 2012). This resolution urged “member states to provide regular drug
treatment of high-risk groups,” with the overarching goal of reaching at least 75% of school
aged, at risk children by 2010 (Humphries D 2012). This resolution went on to recommend
annual deworming in areas where the prevalence of STNs was higher than 20%.(Humphries
D 2012) In an effort to control morbidity, the WHO launched a project to control soil
transmission, which was first initiated in Asia (2004), East Africa (2005) and West Africa
(2006) (Jiraanankul, Aphijirawat et al. 2011). As of 2013, the WHO continued to
recommend annual or biannual treatment in endemic regions, with a focus on increasing
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coverage in regions that did not meet coverage criteria. Alongside mass drug administration,
improvements in water, sanitation, and socioeconomic status in Asia and Latin America have
contributed to a decrease in the overall prevalence of hookworm infection (Brooker S 2004).
However, rates of infection in sub-Saharan Africa continue to be high, as poor education,
limited access to adequate health care, and unsanitary living conditions continue to provide
conditions which favor transmission (Bungiro R 2011).

i. Previous Study in Ghana
Previous studies have found a high degree of variability of hookworm prevalence
across Ghana. A cross-sectional study conducted throughout Ghana in 2011 found the
prevalence of hookworm infection to be highly focal, with cases observed in mostly Central
and Northern Ghana (Figure 2) (Soares Magalhaes, Biritwum et al. 2011).
Figure 3: Hookworm and Schistosome Mono- and Co-infections in Ghana Among Children
ages 5-19

Soares Magalhaes, R. J., et al. (2011). "Mapping helminth co-infection and co-intensity:
geostatistical prediction in ghana." PLoS Negl Trop Dis 5(6): e1200.
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A recent study conducted in Southern Ghana found a higher prevalence of infection in
rural areas than in urban areas (13.6% vs. 0.1%), while a study conducted in the Volta region
of Eastern Ghana found a 9.8% prevalence (van Mens, Aryeetey et al. 2013, Egbi, SteinerAsiedu et al. 2014). In a study examining over 20,000 participants from 216 villages in
Northern Ghana, all but one village (99.5%) had at least one case of hookworm present, with
an overall prevalence of 50% (Yelifari, Bloch et al. 2005). Most studies found that
participants were predominantly infected with Necator americanus, although Anclystoma
duodenale was found in 20% of participants (de Gruijter, van Lieshout et al. 2005, Soares
Magalhaes, Biritwum et al. 2011).
Previous research in Kintampo found a high prevalence of low intensity hookworm
infections in Kintampo North prior to treatment (Humphries D 2012). Data from 2007 across
four communities found a cure rate of 61% following administration of single dose
albendazole therapy (Humphries D 2012). The fecal egg count reduction (FECR) rate was
below the 90% mark for an effective therapy, at 82% (Humphries D 2012). A study of 16
schools in 13 communities in Kintampo in 2010 again found sub-optimal cure rate (44%) and
FECR rate (87%) (Humphries D 2012). A 2011 study in five contiguous Kintampo
communities again noted sub-optimal cure (37.2%) and FECR rate (60.4%) (Humphries D
2012). While the cure rate and FECR rate were relatively low in this study, albendazole
response was highly variable across the five communities (Humphries D 2012). Most
recently, study in Kintampo found a 39% prevalence of infection with a 43% cure rate and
FECR rate of 87.3% after one dose of albendazole (Humphries D 2013). Given the
moderately low cure rates and FECR rate observed in these studies, further investigation is
warranted in order to ensure that resistance is observed as it arises.
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j. Study Rationale and Objectives
The emergence of reduced albendazole efficacy for hookworm infection has major
worldwide implications. We hypothesized that the decreasing effectiveness of albendazole
therapy was due to reduced susceptibility of the parasite. This study provides important
data about parasitic factors that may be contributing to a decrease in albendazole
susceptibility. In order to evaluate this hypothesis, the primary objectives of this study were
to:
1. Determine the baseline prevalence, intensity, and epidemiology of hookworm
infection in four villages in Kintampo North Municipality. These villages (Jato,
Cheranda, Mahama and Tahiru) previously exhibited high and low cure rates
following albendazole therapy.
2. Determine the relationship between clinical response and in vitro albendazole
susceptibility using human hookworm isolates.
3. Extract genomic DNA for future studies aimed at defining the molecular
basis of albendazole resistance in Kintampo North.
4. Identify the species of hookworm from each positive sample
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II.

Methods
a. Ethical Approval and Informed Consent
The Yale University Human Investigation Committee (HIC) approved both field and

laboratory components of this project in May, 2013 under protocol number 1304011926.
Approval was also given by the Noguchi Memorial Institute for Medical Research (NMIMR)
investigational review board (IRB), the Ghanaian Ministries of Health and Education, the
Kintampo Health Research Centre (KHRC), the chiefs and elders of each community and the
teachers and directions from each school.
Preliminary steps to begin recruiting participants began in May, 2013 when the
research team initiated meetings to discuss the study protocol with directors at the Ministry of
Health and Education and the Kintampo Health Research Center. After reviewing census data
compiled in November 2012, it was determined that 226 children from 4 villages along the
Techiman-Tamale highway north of Kintampo were eligible to be recruited for this study.
Study subjects were included in the study if they: 1) resided within the study area, 2) were
between the ages of 7-12, and 3) were willing and able to give consent. Children were
excluded from the study if they were already enrolled in an ongoing longitudinal study
conducted by colleagues at the NMIMR. Under the approved protocol, every child that met
entry criteria would be asked to enroll in the study.

b. Study Site:
This study was conducted between May and July, 2013 along a 30km stretch of the
Techiman-Tamale highway in Kintampo North Municipality, Ghana, between Tahiru (the
southernmost village) and Cheranda (the northern most village) (Figure 1). Kintampo is part
of the Brong Ahafo region of central Ghana, which predominantly agricultural, and cocoa,
yam and cassava are frequently grown in this region. Farming is the most common
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occupation, and sanitation and access to clean water are limited. Helminth infections are
highly prevalent, especially among primary school children.

Figure 4: The Techiman-Tamale Highway in Kintampo North Municipality, Ghana

c. Study Participant Recruitment and Consent:
Meetings were initiated with local chiefs and elders in each village in order to discuss
the study. Following approval, community meetings were set up in order to explain the
purposes of the study to all interested parties in each village. All meeting were conducted by
Ghanaian colleagues in the local language, Twi, to ensure that the study purposes were
clearly understood. Following community meetings in each of the villages, potential study
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participants were visited at their homes. Ghanaian colleagues reiterated the purposes of the
study in Twi to children and their parents. For those that agreed to participate, written consent
forms were signed by the child and their parent and a copy of the consent form was given to
all enrolled participants for reference. After visiting the homes of all potential participants,
the final study population consisted of 179 children ages 7-12 from 4 separate villages: Jato,
Cheranda, Mahama and Tahiru.

d. Questionnaire
Upon enrollment into the study, the parent or guardian of each study participant was
given a household questionnaire by two assistants from the Kintampo Health Research
Center. This questionnaire contained questions that were included in a more extensive
questionnaire conducted in January, 2013 when the community census took place. Interviews
were conducted in Twi, and gathered information about the child’s school and community,
along with information about the household in which they lived. This assessment provided
information about potential confounders including basic information about the child, age,
socioeconomic status, and any environmental exposures that may have varied from household
to household (Appendix 1).

e. Fecal Collection, Processing & Treatment:
Following consent, 500ml fecal collection cups were administered to each study
participant. Children were instructed to fill the cups with fresh portions of their morning
stool, and the following day, cups were collected from each child and taken back to the
Kintampo Health Research Center in a cooler. The Kato-Katz technique was used in
duplicate for each sample in order to identify a positive infection.(Katz N 1972) Laboratory
personnel identified the presence or absence of parasite ova through the use of microscopy
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and the number of eggs were counted on both slides and averaged. In order to calculate the
total number of eggs per gram, the average was multiplied by a factor of 24. All samples that
had at least one hookworm ova present were set aside for further processing. In addition to
examining slides for hookworm ova, slides were counted for Ascaris lumbricoides, Trichuris
trichiura, Taenia spp., and Hymenolepis nana and counts were recorded for future reference.
A small amount of stool was set aside from each positive sample and pooled together
by village. Each pool was used in the Baermann method (Appendix 3) in order to hatch
hookworm ova and isolate hookworm larvae for future analysis. Hookworm ova were
extracted from the remaining stool for each infected study participant (Appendix 2), and egg
hatch assays were set up for samples that had a high enough number of eggs in order to
measure pre-treatment susceptibility to albendazole (Appendix 4). The remaining extracted
eggs were frozen in the lab for future analysis.
Each child that was positive for hookworm was treated with a single dose of 400mg
albendazole within a week of laboratory diagnosis. Ten to fourteen days after treatment, a
second stool sample was collected and the Kato-Katz technique was again repeated in order
to identify positive infections. Egg extractions, Egg Hatch Assays and the Baermann method
were conducted for all positive post-treatment samples and eggs were frozen for future
analysis. Children that were infected with hookworm post-treatment were given an additional
dose of 400mg albendazole within a week of identification. At this time, children with other
parasitic infections were also treated with albendazole (T. trichiura) or praziquantel (H.
nana).

f. Molecular Methods:
Following the completion of post-treatment collections, genomic DNA was extracted
at the Kintampo Health Research Center from all pre- and post-treatment eggs using the
QIAamp DNA stool Kit (Qiagen). Larvae samples were pelleted down, and both extracted
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DNA from eggs and pelleted larvae were taken back to the Cappello laboratory for future
analysis.
Starting in September of 2013, the Cox-1 polymerase chain reaction (PCR) protocol
was used in order to determine which species of hookworm (Necator americanus or
Ancylostoma duodenale) was present in samples. PCR products for both NA and AD were
used in gel electrophoresis, and those with visible product were extracted in order to obtain
purified DNA. Purified DNA was combined with primer and TBE buffer and sent to a lab at
the Yale School of Medicine for sequencing. Sequences were returned for each product and
BLASTed on the NCBI database. This was done in order to see if sequences matched other
Necator americanus or Ancylostoma duodenale isolates within the database. Those that were
matches were noted as confirmed cases of either subtype.

g. Data Analysis:
There are three measurements that were calculated to access drug effectiveness: the
fecal egg count reduction rate (FECR), the cure rate (CR), and the hatch rate (HR)
(Vercruysse J 2011). While the cure rate tells us about the change in the prevalence of the
disease, the egg reduction rate tells us the percentage decrease from baseline to posttreatment levels (Anantaphruti M 2007). The hatch rate calculates in vitro susceptibility of
hookworm eggs to albendazole.

FECR =
CR =

Mean EPG 𝑏𝑒𝑓𝑜𝑟𝑒 deworming−Mean EPG 𝑎𝑓𝑡𝑒𝑟 deworming
Mean EPG 𝑏𝑒𝑓𝑜𝑟𝑒 deworming

∗ 100%

% Prevalence 𝑏𝑒𝑓𝑜𝑟𝑒 treatment−% Prevalence 𝑎𝑓𝑡𝑒𝑟 treatment
% Prevalence 𝑏𝑒𝑓𝑜𝑟𝑒 treatment

∗ 100%

number of hatched larvae

HR = number of hatched larvae+number of remaining eggs ∗ 100%
At the conclusion of the study, the CR and FECR were compared between the two
villages. Those individuals that were still excreting eggs in their stool (treatment failures)
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were given another dose of 400 mg albendazole. Only study subjects with complete data
sets were included in the analysis stage. Data was stored in Microsoft Excel, and statistical
analysis was conducted with SAS version 9.3. Descriptive statistics detailing
demographics, socioeconomic status, nutritional status, and hookworm infection intensity
were also calculated for the two groups of children. Univariate statistical analyses of preand post-treatment study populations will be used for descriptive purposes. The ChiSquared test was used to examine differences between populations and groups, while Ttests were used for continuous variables. Unadjusted logistic regression was used to identify
explanatory variables, which were then used in multivariate analysis. This statistical
technique allowed for the assessment of any factors that could be mediating decreased
albendazole susceptibility.
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III.

Results

a. Study Population:
At the time of enrollment, 226 children were eligible in the four communities to enroll
in the study. Of these, 179 were enrolled in the study and fecal samples were received from a
total of 178 children. Fifty-seven children were hookworm positive after baseline collections,
while 121 children were negative for hookworm infection. All 57 children that were
hookworm positive at baseline were treated with a single dose of 400mg albendazole. Posttreatment (10-14 days) samples were received from all 57 children. Of these, 36 children
fully responded to treatment and were hookworm negative, while 21 children were still
positive for hookworm infection.
Figure 5: Characteristics of Study Population
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b. Baseline Characteristics of Study Population:
Table 1. Demographic and Socioeconomic Indicators of the Study Population at Baseline
Study Population (N = 178)b
Characteristic
9.45 ± 1.72
Age (years)
Sex
Female
50 (89)
Male
50 (89)
16.75 ± 4.1
Body Mass Index
11.54 ± 6.94
Average Household Size
Absolute Wealth
Low
33.15 (59)
Middle
42.70 (76)
High
24.16 (43)
Ownership of agricultural land
Yes
81.46 (145)
No
18.54 (33)
Household savings account
Yes
52.25 (93)
No
47.75 (85)
Daily use of a Latrine or Toilet
Yes
21.91 (39)
No
78.09 (139)
Primary Religion
Muslim
12.92 (23)
Christian
70.22 (125)
Traditional
12.36 (22)
Other
4.49 (8)
Attends School
Yes
95.51 (170)
No
4.49 (8)
Daily Shoe Usage
Yes
82.58 (147)
No
0.17 (31)
a

Table values are column % (N) for categorical variables and mean + SD for continuous
variables
b
Numbers may not sum to total due to missing data and percentages may not sum to 100%
due to rounding

Initial analysis of the baseline population was done with univariate statistics in SAS v.
9.3. The average age of children enrolled (n=178) was 9.5 years old. Eighty-nine (50%) study
participants were male while 89 (50%) were female. Children had an average body mass
index of 16.75 and only 8 children (4.49%) did not attend school. There were approximately
12 people per household, and the majority of households owned agricultural land (81.5%)
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and were Christian (70.22%). Most children had daily access to a toilet or latrine (78.09%)
and wore shoes daily (82.58%).
An absolute wealth index was calculated using data from 18 measurements in order to
estimate the approximate wealth of each household.(Filmer and Pritchett 2001) This measure
of socioeconomic status included a variety of variables from the household questionnaire
(ownership of pigs, poultry, goats or sheep, horses or donkeys, a tile floor, use of advanced
cooking fuel, electricity, radio, TV, phone, refrigerator, bike, car or motorcycle, ownership of
land,a bank or savings account, improved water source, and an improved toilet ) in order to
compare absolute wealth at the community level.(Filmer and Pritchett 2001, Humphries D
2013) The mean absolute wealth index across the study was 6.08 with a standard deviation of
2.065. Children from Mahama had the lowest absolute wealth index (5.667), while children
in Jato had the highest absolute wealth index (6.437).

Figure 6: Absolute Wealth Index by Village
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c. Prevalence of Intestinal Helminth Infections at Baseline:
After screening, the highest prevalence of Helminth infection was hookworm
infection, which occurred in 32.02% of study participants (n=57) (Figure 6). Trichuris
trichiura was observed among 1.12% of study participants (n=2) while Hymenolepis nana
was found among 12.92% (n=23) study participants (Figure 6). Although fecal smears were
examined for Ascaris lumbricoides and Taenia saginata, no cases were detected among study
participants at baseline.

Figure 7: Prevalence of Intestinal Helminth Infections at Baseline
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Hookworm infection was found in all four communities (figure 7) with varying levels
of infection. T. trichiura was observed only in Cheranda, while H. nana was observed across
all four communities, with the highest prevalence in Mahama, where 25% of study
participants were infected. No cases of A lumbricoides or T. saginata were observed among
study participants at baseline.
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Figure 8: Prevalence of Intestinal Helminth Infections at Baseline by Villagea
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Ascaris lumbricoide and Taenia saginata excluded due to 0% prevalence among study
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Out of a a possible 178 study participants, 103 (57.87%) had no visible helminth eggs
of any species in their stool (Figure 8). Few (1.12%) subjects were positive for T. trichiura,
while 8.99% (n=16) of participants were positive for only H. nana (Figure 8). Isolated
hookworm monoinfection was observd in 23.09% of participants (n=50), while 3.93% (n=7)
of participants were co-infected with hookworm and H. nana.
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Figure 9: Intestinal Helminth Mono- and Co-infection at Baseline (n=178)
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d. Prevalence & Intensity of Hookworm Infection at Baseline:
After collecting initial baseline stool samples from each of the study participants, a
total of 57 children from all four communities were positive for hookworm. While 3.51% of
hookworm positive cases were from Tahiru (N=2), 8.77% of cases (N=5) each came from
Mahama and Cheranda, and 78.95% of cases (N=45) were from Jato (Figure 3). Although the
highest number of cases came from Jato, both Jato and Mahama had high prevalences of
hookworm (43.69% and 42.67% respectively) while Tahiru (8.00%) had the lowest
prevalence (Figure 3).
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Figure 10: Pre-treatment Hookworm Prevalence by Village
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Almost all cases (98.25%) were characterized as having a light infection (Table 2).
Only one child from Jato was noted to have a heavy infection of over 4000 eggs per gram
(EPG). Children that were infected at baseline had a mean egg count of 443epg, and egg
counts ranged from 12-6336epg among the sample of children positive at baseline (Table 2).

Table 2. Intensity of Hookworm Infection at Baseline
Classificationa
N (%)b
Light (1-1,999 Eggs per gram)
56 (98.25)
Moderate (2,000-3,999 Eggs per gram)
0 (0)
Heavy (>4000 Eggs per gram)
1 (1.75)
a
Based on WHO criteria (Pawlowski Z 1991)
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e. Demographic and Socioeconomic Analysis of the Baseline Study Population by Infection
Status
After collecting and processing all stool samples, univariate statistics were computed
for a variety of variables based on hookworm infection at baseline. Continuous variables
were analyzed using t-tests while chi-squared tests were used for categorical and binary
variables. Children that were positive at baseline were slightly younger (9.13 years old)
than those that were uninfected (9.69 years old), although this was not statistically
significant (p=0.10). Gender, Body Mass Index (BMI), Pig Ownership, Land ownership
and Absolute Wealth index were also non-significant between hookworm positive and
hookworm negative subgroups (p=0.6298, 0.8562, 0.6494, 0.2885 and 0.2629
respectively). Religion was found to be significant (p=0.0278) and Christians and
Traditionalists had the highest number of positives. Tribal identity was highly significant
(p<0.0001), with almost all positive cases from the Konkomba and Chokose tribes, and
no cases among the Mo tribe. The average household size was also significantly higher
among children that were infected at baseline as compared to children that were
uninfected (p=0.002). There was higher prevalence of infection among children who did
not attend school at baseline (p=0.008) (Table 3).
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Table 3. Demographic and Socioeconomic Indicators of the Study Population by
Hookworm Infection Status at Baselinea
Hookworm Infection
% Negative (N
% Positive (N = 57)b
= 121)b
Characteristic
pc
9.13 ± 1.71
9.69 ± 1.71
0.1000
Age (years)
0.6298
Sex
Female
47.37 (27)
51.24 (62)
Male
52.63 (30)
48.76 (59)
16.65 ± 5.97
16.80 ± 2.85
0.8561
Body Mass Index
0.0002
Village
Cheranda
8.77 (5)
27.27 (33)
Jato
78.95 (45)
47.93 (58)
Mahama
8.77 (5)
5.79 (7)
Tahiru
3.51 (2)
19.01 (23)
0.0001
Tribe
Konkomba
68.42 (39)
53.72 (65)
Mo
0.00 (0)
17.36 (21)
Chokose
29.82 (17)
15.70 (19)
Other
1.75 (1)
13.22 (16)
0.2629
Absolute Wealth Index
Low
28.07 (16)
35.54 (43)
Medium
40.35 (23)
43.80 (53)
High
31.58 (18)
20.66 (25)
0.0278
Primary Religion
Muslim
5.26 (3)
16.53 (20)
Christian
70.18 (40)
70.25 (85)
Traditional
21.05 (12)
8.26 (10)
Other
3.51 (2)
4.96 (6)
0.0077
Attends School
Yes
89.47 (51)
98.35 (119)
No
10.53 (6)
1.65 (2)
13.82±6.78
10.48±7.82
0.0023
Average household size
0.2885
Ownership of Land
Yes
85.96 (49)
79.34 (96)
No
14.04 (8)
20.66 (25)
0.6494
Ownership of Pigs
Yes
19.30 (11)
16.53 (20)
No
80.70 (46)
83.47 (101)
a
Table values are mean + SD for continuous variables and column % (N) for categorical
variables
b

Numbers may not sum to total due to missing data and percentages may not sum to 100%
due to rounding
c

p-value is for t-test (continuous variables) or x2-test (categorical variables)
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Daily use of a toilet or latrine was also found to be highly statistically significant
(<0.0001), with only one case among children that used a toilet or latrine daily (Table 4).
Infection with another helminth infection (Trichuris or H. nana), daily shoe usage, and
antiparasitic treatment in the last year were not found to be significantly associated with
hookworm infection (p=0.6420, 0.3799, 0.8795 respectively).

Table 4. Host Factors of the Study Population by Hookworm Infection Status at Baselinea
Hookworm Infection
% Positive (N = % Negative (N =
57)b
121)b
Characteristic
pc
0.6420
Infection with another Helminth
Yes
12.28 (7)
14.88 (18)
No
87.72 (50)
85.12 (103)
0.3799
Daily Shoe Usage
Yes
78.95 (45)
84.30 (102)
No
21.05 (12)
15.70 (19)
<0.0001
Daily Toilet or Latrine Use
Yes
1.79 (1)
31.40 (38)
No
98.25 (56)
68.60 (83)
Antiparasitic treatment in the last
0.8795
year
Yes
24.56 (14)
25.62 (31)
No
75.44 (43)
74.38 (90)
a
Table values are mean + SD for continuous variables and column % (N) for categorical
variables
b

Numbers may not sum to total due to missing data and percentages may not sum to 100%
due to rounding
c

p-value is for t-test (continuous variables) or x2-test (categorical variables)
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f. Risk Factors for Hookworm Infection at Baseline
Using the risk factors for infection, unadjusted logistic regression was used to identify
variables for use in multivariate regression analysis. Odds ratios were adjusted for age,
religion, body mass index (BMI), absolute wealth index, land ownership, infection with
another helminth, and antiparasitic treatment in the last year. School attendance and daily
toilet or latrine use were found to be risk factors for hookworm infection (p=0.0137 and
0.0482 respectively), as was tribe. Specifically, being a member of the Konkomba or
Chokose tribe was associated with an increased risk of having hookworm infection
(p=0.0470 and 0.0439 respectively), while being a member of the Mo tribe was highly
non-significant (p=0.9685) (Table 5).

Table 5. Risk Factors for Hookworm Infection at Baselinea
Adjusted Odds
Characteristic
Ratio
95% Confidence Interval
Male
0.863
0.391-1.906
Village
(reference=Tahiru)
1.00
Cheranda
0.780
0.020-30.680
Jato
0.356
0.013-9.597
Mahama
0.857
0.031-23.420
Tribe
(Reference=other)
1.00
Konkomba
28.090
1.045-755.150
Mo
600443
1.102->999
Chokose
<0.001
<0.001->999
Household size
1.053
0.993-1.117
Pig Ownership
0.635
0.209-1.930
Daily Shoe Usage
1.881
0.684-5.176
Attends School
0.034
0.002-0.500
Daily Toilet or
Latrine Use
0.011
<0.001-0.965
a
Adjusted for all other variables in this model

pc
0.7163

0.8942
0.5389
0.9270

0.0470
0.0439
0.9685
0.0829
0.4230
0.2209
0.0137
0.0482
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g. Post-Treatment Demographic and Socioeconomic Assessment Based on Treatment
Response
Table 6. Demographic and Socioeconomic Indicators of the Treatment Population by PostTreatment Hookworm Infection Statusa
Hookworm Infection
% Positive (N = 21)b % Negative (N = 36)b
Characteristic
pc
8.95 +/- 1.82
9.38 +/- 1.71
0.3829
Age (years)
0.9769
Sex
Female
47.37 (10)
47.22(17)
Male
83065 )91(
52.78 (19)
15.82+/- 1.83
17.13 +/- 7.38
Body Mass Index
Village
Cheranda
0.00 (0)
13.89 (5)
Jato
95.24 (20)
69.44 (25)
Mahama
1.75 (1)
11.11 (4)
Tahiru
0.00 (0)
5.56 (2)
Tribe
Konkomba
66.67 (14)
69.44 (25)
Chokose
0.00 (0)
0.00 (0)
Mo
33.33 (7)
27.78 (10)
Other
0.00 (0)
2.78 (1)
Absolute Wealth Index
Low
28.57 (6)
27.78 (10)
Medium
33.33 (7)
41.67 (15)
High
38.10 (8)
30.56 (11)
Primary Religion
Muslim
9.52 (2)
2.78 (1)
Christian
71.43 (15)
69.44 (25)
Traditional
19.05 (4)
22.22 (8)
Other
0.00 (0)
5.56 (2)
Attends School
Yes
95.24 (20)
86.11 (31)
No
4.76 (1)
13.89 (5)
12.76 ± 6.76
14.44 ±8.41
Average Household Size
Ownership of Land
Yes
80.95 (17)
91.67 (33)
No
19.05 (4)
8.33 (2)
Ownership of Pigs
Yes
9.52 (2)
25.00 (9)
No
90.48 (19)
75.00 (27)
a
Table values are mean + SD for continuous variables and column % (N) for categorical
variables

0.3183
0.1212

0.6923

0.7914

0.4965

0.2788

0.4384
0.2345

0.1532

b

Numbers may not sum to total due to missing data and percentages may not sum to 100%
due to rounding
c

p-value is for t-test (continuous variables) or x2-test (categorical variables)
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Table 7. Host Indicators of the Treatment Population by Post-Treatment Hookworm Infection
Statusa
Hookworm Infection
% Positive (N = 21)b % Negative (N = 36)b
Characteristic
pc
0.1152
Infection with Another Helminth
Yes
14.29 (3)
47.22(17)
No
85.71 (18)
66.67 (24)
0.6966
Daily Shoe Usage
Yes
76.19 (16)
80.56 (29)
No
23.81 (5)
19.44 (7)
0.4410
Daily Toilet or Latrine Usage
Yes
21 (100.00)
2.78 (1)
No
0 (0.00)
97.22 (35)
Antiparasitic Treatment in the
0.5911
last year
Yes
28.57 (6)
22.22 (8)
No
71.43 (15)
77.78 (28)
a
Table values are mean + SD for continuous variables and column % (N) for categorical
variables
b

Numbers may not sum to total due to missing data and percentages may not sum to 100%
due to rounding
c

p-value is for t-test (continuous variables) or x2-test (categorical variables)

Post-treatment univariate analysis was conducted among children that received
treatment and submitted a second fecal sample. This analysis was divided between children
that were positive and children that were negative post-treatment, and no variables were
found to be significantly associated with post-treatment response (Table 6 and 7).

h. Cure Rate and Fecal Egg Reduction Rate
Following examination of post-treatment isolates, the overall cure rate among infected
children (n=57) was 63.2% (n=36) (Figure 11). The highest cure rates were observed in both
Tahiru and Cheranda (100%), Mahama had a cure rate of 80% and the lowest cure rate was
observed in Jato, where only 55% of children were cleared of infection following a single
dose of the drug.

32 | P a g e

Figure 11: Community Variation in Response to Treatment
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Table 8. Hookworm Cure Rate and Egg Reduction Rate of the Treatment
Group
Prevalence (%)
Baseline
100
Post-Treatment
36.84
63.2
Cure Rate (%)
Arithmetic Mean Egg Counta
Baseline
442.53 + 909.19
Post-Treatment
112.00+ 191.97
90.7
Egg Reduction Rate (%)
a
Eggs per gram
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Children at baseline had a higher mean egg count (442.53epg) than children that were
positive following a single dose of albendazole (112epg) (Table 8). There was also more
variation in egg count among children that were positive at baseline (standard deviation +/909epg) and children that were positive post-treatment (191.97). All children that were
positive post treatment (n=21) had a light infection (less than 1,999 eggs per gram).

i. In Vitro Susceptibility of Hookworm Isolates
Egg hatch assays (EHA) were set up for samples that had counts greater than 10
eggs/30µl, and incubated at room temperature for 24 hours. 20 pre-treatment samples and 4
post-treatment samples had high enough egg counts to be used in the EHA. Figure 12 shows
that for both pre- and post-treatment samples, as the concentration of albendazole increases,
fewer eggs hatch. The median egg hatch rate at the highest concentration was similar at
concentrations of 2, 5 and 10 µg/ml, and higher post-treatment at 1 µg/ml. However, these
comparisons are limited due to the very low number of EHA data from post-treatment
samples.
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Figure 12: Susceptibility of Hookworm eggs to Albendazole at Increasing
Concentrations Before and After Treatment
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j. Identification of Hookworm Species using PCR:
After setting up PCRs for all pre-treatment samples, a total of 39 yielded product during
gel electrophoresis. After extracting all bands from the gel and submitting the purified
products for sequencing, a 15/16 of the samples submitted for Necator americanus were
confirmed through sequencing, while 0/23 products were confirmed for Ancylostoma
duodenale. Based on these results, all confirmed isolates were positive for Necator
americanus, and there were no confirmed Ancylostoma duodenale positive sequences.
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IV.

Discussion

Epidemiology of Hookworm Infection
Soil-transmitted nematodes (STNs) including Ascaris lumbricoides, Trichuris
trichiura, and hookworms are estimated to infect one out of every two people in developing
countries (Humphries D 2012). Hookworm is a STN estimated to infect 740 people around
the world, with the highest prevalence in sub-Saharan Africa (29%), where nearly 200
million people are infected (Humphries D 2012). STN infections have been targeted by a
variety of control measures, including but not limited to health education, the introduction of
latrines and better sanitary practices and chemotherapy (Albonico A, 1997). In recent years,
the World Health Organization has taken an active role in trying to lower the disease burden
and DALYs associated with STN infections through the use of mass drug administration
(MDA). Currently, the World Health Organization (WHO) recommends annual deworming
in areas with more than a 20% prevalence of STN infection and bi-annual treatment to
regions where prevalence is 50% or higher. Worldwide, a single dose of albendazole is one of
the recommended treatments for hookworm infection.
In Ghana, the prevalence of STN infections ranges from 40% in the central region to
87% in the north (Humphries D 2012). Previous study on hookworm infection in Kintampo,
Ghana reported a prevalence of 45% in 2007, 39% in 2010, and 57% in 2011 (Humphries D
2012). This study found a lower prevalence of hookworm infection (32%) among the study
population than in previous years. Similar to previous study in Kintampo, nearly every child
(98.25%) harbored a light infection (1-1,999 eggs per gram) at baseline, and all children were
lightly infected after treatment.
Previous study in Kintampo found other intestinal parasites including Hymenolepis
nana and Taenia spp. to infect 15% of the study population. Notably, Ascaris lumbricoides
and Trichuris trichiura were not observed among any participants. This study found both H.
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nana (12.92%) and T. trichiura (1.12%) to be present in the study population, while A.
lumbricoides and Taenia spp. were absent.
Human hookworm infection is primarily caused by two species of hookworm,
Necator americanus and Anclystoma duodenale.(van Mens, Aryeetey et al. 2013) Infection
with hookworms is endemic in many countries across sub-Saharan Africa. In Ghana, N.
americanus is considered to be the predominant species, although studies have found that A.
duodenale can coexist (de Gruijter, van Lieshout et al. 2005, van Mens, Aryeetey et al. 2013).
Previous study in Kintampo in 2010 found most children to be infected with N. americanus
(91.2%) (Humphries D 2013). Coinfection with A. duodenale to occur in a few cases (1.9%),
and no isolated A. duodenale infections were observed during this study (Humphries D
2013). This study reaffirmed previous studies, finding 16/16 sequences to be positive for
Necator americanus following DNA extractions and PCR. Although no Ancylostoma
duodenale were observed in isolates, this may be due to the low number of successful isolates
sequenced (16/78), and further analysis of these samples is warranted.

Risk Factors for Infection
Given its association with rural poverty, risk factors for hookworm infection are
consistently reported to be related to socioeconomic status. Limited access to clean water,
sanitation and adequate health care, along with poor education provide an environment
around which transmission can continue. Previous study in Kintampo identified education
level, occupation, and malaria parasitemia to be risk factors for infection in 2007. A 2010
study in Kintampo found pig ownership, parental occupation (farmer), larger household sizes,
and not seeing a health care provider in the last year to be significantly associated with
infection at baseline. This study found religion, village, tribal identity, not attending school, a
larger household size, and not using a toilet or latrine daily to be statistically significant at the
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0.05 level, indicating an association with helminth infection at baseline. Both school
attendance and a larger household size are consistent with previous findings in Kintampo.
Notably, this study was the first in Kintampo to identify religion, tribe and not using a toilet
or latrine daily to be significantly associated with hookworm infection at baseline.
Following analysis with Multivariate Logistic Regression, risk factors for infection at
baseline were identified. It was found that children that attended school had an Odds Ratio
(OR) of 0.03 (p=0.01), indicating that school attendance was protective for infection with
hookworm. This finding is consistent with previous study in Kintampo, which identified a
higher education level as a protective factor for infection. Having daily access to a latrine was
associated with a decreased risk for infection (OR=0.01), and children that had daily access
were approximately ten times less likely to be infected than children that did not have daily
access (p=0.049). While this was not found previously in Kintampo, lack of access to latrines
has been found to be a risk factor for infection in previous studies (Chongsuvivatwong, PasOng et al. 1996, Olsen, Samuelsen et al. 2001).
This was the first time that questions about tribal identity were asked to study
participants in Kintampo. Findings demonstrated that being a member of the Konkomba or
Mo tribes was associated with infection at baseline (p=0.047 and 0.044 respectively), while
being a member of the Mo tribe was highly protective, with no cases of hookworm at
baseline (p=0.969).

Treatment Efficacy
A single dose of albendazole (400mg) is frequently used in mass drug administration
(MDA) campaigns as the primary drug recommended for the treatment of hookworm
infection. Studies have found cure rates following administration to range from 33-95% and
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the fecal egg count reduction rate to range from 64% to 100% (Keiser J 2010, Humphries D
2013, Samuel, Degarege et al. 2014).
Previous study in Kintampo found that cure rates (CR) after administration of a single
dose of albendazole were shown to decrease over time, as 61% of the study population
treated at baseline cleared infection in 2007, 43% cleared infection in 2010, and 39.5%
cleared infection in 2011 (Humphries D 2012). Similarly, the mean fecal egg count reduction
rate (FECR) fell from 81.5% in 2007 to 70.9% by 2011. This study found a higher cure rate
(63.2%) and fecal egg count reduction rate (90.7%) than in previous years. While these data
show the drug to be more effective than previously thought, there was a large degree of
variation in treatment response at the community level.
Data from 2011 indicated that there was large variation in treatment response between
villages. None of the treated children from Jato were cleared of infection after treatment and
the mean FECR among children treated was only 1.2% (Humphries D 2012). In comparison,
the cure rate in neighboring village Cheranda was 81.8%, with a mean FECR of 96.3%
(Humphries D 2012). This study was conducted as a follow-up in order to further examine
these differences in treatment response.
During previous years, a sample of children were enrolled from each community to
provide an estimate of the disease burden in each community. This study enrolled every
available child from both Jato and Cheranda, along with children from Mahama and Tahiru.
The prevalence of infection varied by community, with 45% of children positive for
hookworm in Jato, and 8.0% of children positive in Tahiru. The Fecal Egg Reduction Rates
(FECR) and Cure rates (CR) were highest in Cheranda and Tahiru (100%) and lowest in Jato,
where only 55% of children were cured of infection, and 87.5% of children experience a
reduction in their egg counts. As was seen in Cheranda, Mahama, and Tahiru, nearly every
child responded to therapy and was cleared of infection after a single dose of the drug (CR=
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91.67%). In Jato, a village that neighbors both Cheranda and Mahama, 44.44% of children
were positive for infection after treatment (CR=55.56%). Together, these data provide
evidence that the effectiveness of albendazole treatment varies widely at the community
level. These findings are consistent with data from the 2011 field study in Jato and Cheranda,
which similarly observed differences in treatment response by community.
While these findings demonstrate a wide degree of variability in baseline prevalence
and treatment response between villages, it is important to note that each community is not
independent. Interestingly, all five cases of hookworm in Cheranda were in homes that were
on the outskirts of town, nearest Jato. While this study did not take GPS coordinates of each
home, the fact that each positive case from Cheranda came from locations nearest Jato is
important to keep in mind.

Study Limitations
Limitations of this study include the use of the Kato-Katz technique to diagnose
infection. The Kato-Katz is recommended by the WHO as a useful technique that provides an
indirect measure of worm burden (Montresor A. 1998). However, its use is expected to
underestimate the disease burden within a community (Montresor A. 1998). This is especially
problematic for samples that have been left out, as hookworm eggs rapidly deteriorate in
stool (Montresor A. 1998). This deterioration could result in an underestimation of the burden
of disease, due to the fact that it becomes less likely that a positive sample will be read
correctly. To lessen this risk, samples were quickly returned to the laboratory after being
collected, and slides were read within a few hours of collection.
Similarly, the effectiveness of the drug could have played a role in the response to
treatment. However, every precaution was taken in ensuring that a viable drug was obtained,
and that each child took the medication correctly. Doses of albendazole were obtained from
the Kintampo Municipal Hospital, and trained assistants administered the drug to each
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infected child. Each child was observed taking the medication, so as to eliminate the
possibility that the infected child didn’t take the drug.
Other limitations of the study include the use of the questionnaire, which may not
have assessed health risk factors for infection. Data was not collected on several potential risk
factors including rash history, health care access in the last year, or malaria co-infection.
These factors have been found to play a role in infection status and were not assessed over
the course of this study. Recall bias may have played a role in response to several questions,
which could have played a role in the identification of risk factors for infection. Missing data
or inaccuracies in reporting were especially problematic when acquiring birth dates for each
child to confirm their age. The age of each child could not always be confirmed, and data
relied on the parent reporting the correct age of their child.

Conclusions
Ultimately, these data demonstrate the need for more targeted approaches to the
treatment of helminth infections, as variable responses are observed within each community.
Findings from Jato suggest that in some communities, chemotherapy alone is not enough. In
contrast, data from other communities demonstrate that within the right setting, therapeutic
approaches can make significant contributions to decreasing worm burden, at least in the
short term. Yearly or bi-yearly treatment of infected children also increases the chance that a
change in parasite susceptibility will occur. This is especially problematic in communities
like Jato, where a lack of sanitary practices, access to latrines, and access to health education
coincide with high rates of reinfection. As such, those that are cleared of infection with MDA
are likely to become reinfected – thereby negating the purpose of the treatment. Given these
differences in treatment response, these data suggest the need for more targeted interventions
in order to further control helminth infections in the developing world. Control measures such
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as health education or providing access to latrines could make a more substantial impact in
communities like Jato, where MDA has been implemented, and where infection rates
continue to be high among school children. Data from this study further supports the need for
new approaches to combat the disease burden posed by helminth infections in much of the
developing world.
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VI.

Appendices
a.

Appendix 1: Ghana Questionnaire, Summer 2013

IDENTIFICATION
CHILD NAME __________________________________________________________________
DATE OF BIRTH
____________________________(DDMMMYYYY)_________________________
AGE __________________________________________________________________________
SEX □ MALE

1

□ FEMALE

2

HEIGHT _______________(XX.XX cm)_____________________________________________
WEIGHT _______________________(XX.XX KG)____________________________________
SCHOOL/CLASS________________________________________________________________
CHILD ID #_____________________________________________________________________
HEAD OF HOUSEHOLD _________________________________________________________
RESPONDENT NAME____________________________________________________________
RELATIONSHIP OF RESPONDENT TO CHILD_______________________________________
HOUSE NUMBER…………………………………...……………………………………………..
COMMUNITY.…….……………………………………………………………………..................
GPS LATITUDE AND LONGITUDE………………………………………………………………
INTERVIEWER NAME ___________________________________ NUMBER _____________
INTERVIEWER NAME ___________________________________ NUMBER _____________

QUESTIONNAIRE ANSWERS REVIEWED ______________ (DDMMYYYY Date)
______________ (Initials)

I|Page

1.
NO.

SOCIOECONOMIC INDICATORS

QUESTIONS AND FILTERS

CODING CATEGORIES

ENTER #

1.1

What is the main material of the floor?

NATURAL FLOOR...…..……………...…1
CEMENT FLOOR…...……….…………...2
TILE FLOOR……………………..……….3

1.2

What is the main material of the walls?

Mudbrick ………………………………….1
Brick ……………………………………….2
Other ……………………………………….66

1.3

What is the main material of the roof?

Thatch ……………………………………..1
Metal ………………………………………2
Other ………………………………………66

1.4

What type of fuel does the household mainly use for
cooking?

ELECTRICITY...…………………………….1
NATURAL GAS……………………………..2
BIOGAS……………………………...............3
KEROSENE…..……………………………...4
CHARCOAL ..…………………….................5
FIREWOOD/STRAW …………………….....6
DUNG..…………………………………….....7
OTHER______________________________66
(SPECIFY)

1.5

Does your household have:
1.5a
1.5b
1.5c
1.5d
1.5e
1.5f

YES
ELECTRICITY………….…..….1
RADIO.…………….……....…...1

NO
2
2

TELEVISION..…………..……...1

2

TELEPHONE..………….……....1

2

REFRIGERATOR………………1

2

DVD/VCR .………….……........1

2

1.6

Does any member of the household own:

YES
BICYCLE……………………….1
MOTORCYCLE/SCOOTER…...1
CAR/TRUCK.………………......1

1.7

Does any member of the household own agricultural
land?

YES………………………………………….1
NO..………………………………………….2
DON’T KNOW……………...………….......88

1.8

Does any member of the household own at least one:
1.8a
1.8b
1.8c
1.8d
1.8e
1.8f
1.8g
1.8h

NO
2
2
2

How many?
COW………………..…………HORSE…………………..……DONKEY ……………………..GOAT………………..……..…SHEEP………………..……….POULTRY…...…….….………DOG……………….….……….PIG…………………..….……..-
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1.9

Does anyone in the household own a savings account?

1.10

How far is the household from the nearest health
facility?

YES
BANK…………………..1
CO-OPERATIVE.......….1

NO
2
2

DK
88
88

LESS THAN 1KM………………………...…1
BETWEEN 1 AND 5KM...……………….….2
BETWEEN 5 AND 10KM……………….......3
GREATER THAN 10KM..………………......4
DON’T KNOW………………………………88

1.11

How many people in the household?
1.11a
1.11b
1.11c
1.11d
1.11e

Total number __________________
< 5 yrs
_______________
6-11 yrs
_______________
12-15 yrs
_______________
Women > 15 _______________
Men > 15
________________

1.12

What is the primary religion of the household?

Muslim
Christian
Traditional
Other

1.13

What tribe do you belong to?

2.
NO.
2.1

QUESTIONS AND FILTERS

HOUSEHOLD WATER SOURCES
CODING CATEGORIES

ENTER #

What is the main source of water for members of your
household?
PIPED WATER…………….…...10
DUG WELL....…………..…..…. 11
WATER FROM A SPRING….... 12
RAINWATER…..……………… 13
SURFACE WATER….………… 14
OTHER…………………………. 66
(SPECIFY)
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3.
NO.
3.1

TOILET FACILITIES AND GARBAGE

QUESTIONS AND FILTERS

CODING CATEGORIES

What kind of toilet facility do members of the
household use?

YES

NO

FLUSH OR POUR...…….…..….1
2
PIT LATRINE...…….……..........1
2
COMPOST...………..…………..1
2
BUCKET.………………….…....1
2
BUSH OR FIELD………...…….1
2
RIVER…………………………..1
2
OTHER____________________________ 66
(SPECIFY)

3.1a
3.1b
3.1c
3.1d
3.1e
3.1f
3.1g

4.
NO.

ENTER #

EXPOSURE/DISEASE PREVENTION

QUESTIONS AND FILTERS

CODING CATEGORIES

4.1

Has any member of your household had deworming
medication in the past year?

YES…………………………………….…….1
NO..…………………………………………..2
DON’T KNOW………………………..…....88

4.2

Does the child own shoes?

YES…………………………………….…….1
NO..……………………………………….….2
DON’T KNOW……………...……………....88

4.3

If yes, does the child wear shoes daily?

Almost all the time every day………………1
Some of the time every day…………...……2
Some of the time, not every day……………3
Rarely……………………………………….4
DON’T KNOW……………...……..……....88

ENTER #
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5.

PARASITE TREATMENT

ANTI-PARASITIC
HISTORY

LINE NO.

Antiparasitic treatment in
the past year?
(1)
YES

(2)
NO

Index Child

1

2

Head of Household

1

2

Mother or Caregiver

1

2

03 FROM TABLE 6

1

2

04 FROM TABLE 6

1

2

05 FROM TABLE 6

1

2

06 FROM TABLE 6

1

2

07 FROM TABLE 6

1

2

ANTIPARASITIC
TREATMENT

TREATMENT SOURCE

See treatment codes below

See treatment source codes below

(3)

(4)

TREATMENT CODES
ALBENDAZOLE…………1
PYRANTEL………………3
DON’T KNOW..................88

MEBENDAZOLE……………………………2
OTHER ANTI-PARASITIC______________4
(SPECIFY)

TREATMENT SOURCE CODES
HOSPITAL…….....................1
PHARMACIST…...................3
FAMILY MEMBER…...........5
OTHER_________________ 66
(SPECIFY)

LOCAL CLINIC…................... 2
LOCAL HEALER….................4
DRUG STORE…................…..6
DON’T KNOW………………88

THA
NK

YOU for all of your help. We are very grateful for your time!
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b.

Appendix 2: Egg Extraction Protocol

Purpose: Extract eggs from fecal matter; bring eggs to a known concentration for EHA and/or
concentrate into 200µl to freeze for gDNA extraction.
Items needed PER SAMPLE:
1. Feces
2. 100 ml 0.9% NaCl
3. 40 ml 0.015% Brij-35
4. 40 ml 2.18M NaNO3
5. 3 x 250 ml centrifuge bottles
6. 2 x 50 ml FALCON centrifuge tubes
7. 1 sheet 4”x4” gauze
8. 1 funnel
9. 40 ml of H2O
10. 1x 80 µm filter
11. 1x 20 µm filter
12. Filter apparatus unit
13. 200 ml H2O in a flask or beaker
PROCEDURE
1. Add ~100 ml of 0.9% NaCl directly to sample in stool collection cup
OR
2. Put needed grams of feces into 250 ml centrifuge bottle and add ~100ml 0.9% NaCl
3. Shake vigorously
4. Filter over a single layer of gauze placed in a funnel to remove large particulate
5. COLLECT FILTRATE IN CLEAN 250 ML bottle
6. Squeeze gauze to get as much liquefied sample as possible
7. Centrifuge @500g for 5 minutes
8. Carefully decant supernatant-DISCARD into beaker-EGGS IN PELLET
9. Resuspend pellet in 0.015% Brij-35 measured to 40 ml mark on conical
10. Shake vigorously to resuspend pellet
11. Spin @500g for 5 minutes
12. CAREFULLY open bottle and discard supernatant into beaker-EGGS IN PELLET
13. Add 40 ml with NaNO3 (2.18 M, 1.185 specific gravity); GENTLY resuspend pellet by
inverting
14. Transfer to a 50 ml FALCON centrifuge tube
15. Spin @500g for 10 minutes
-WHILE SPINNING SET UP FILTRATION APPARATUS WITH 80 µm
FILTER
16. Decant top 10 ml into a beaker or flask containing 200 ml water – swirl mix
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17. Pour solution over 80 µm filter in filtration apparatus– apply gentle suction if necessary
-EGGS WILL FLOW THROUGH THE 80 µm FILTER
18. Remove used filter from apparatus; Position clean 20 µm filter
19. Pour flow-through over 20 µm filter- EGGS WILL BE TRAPPED ON 20 µm FILTER
20. FOLD the 20 µm filter into a 50ml conical containing 40 ml of water; Shake to release
eggs trapped on filter>> remove filter paper.
21. Spin @ 500g for 5 minutes
22. Let stand for 90 minutes
23. Gently aspirate down to approximately 1 ml >> EGGS IN BOTTOM OF SOLUTION
24. Resuspend gently and count 20 ul of suspension- adjust to 50 eggs in 100 µl for EHA
25. Dispense 10 wells of 50 eggs/100 µl each for EHA
26. High speed (1000g?) spin remaining eggs to pellet; remove water leaving 200 µl
27. Freeze -20°C.

SOLUTIONS: ALL SOLUTIONS REQUIRE HIGH QUALITY OR DISTILLED WATER
0.9% NaCl: per 1 liter
9 grams of NaCl per 1000 ml H2O
0.015% Brij-35: per liter
0.5 ml of 30% Brij-35 per 1000 ml H2O
NaNO3 (2.18 M, 1.185 specific gravity): per liter
185 grams per 1000 ml H2O
NEEDED FOR 150 SAMPLES:
6 liters 0.9% NaCl; 54 grams NaCl
6 liters 0.015% Brij-35; 3 ml 30% Brij-35
2.25 liters 2.18M NaNO3; 416.25 grams NaNO3
150-300 50 ml FALCON centrifuge tubes
300 x 15 ml FALCON centrifuge tubes
150 sheets gauze
1 funnel
20 ml of H2O
150 x 80 µm filter
150 x 20 µm filter
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Appendix 3: Baerman Funnel Set-up

1. Mix feces with bone charcoal (http://www.ebonex.com/) so that there is an even distribution.
We have found a 5:1 (charcoal:feces) ratio is optimal. If soil is used it should be sterilized. The
mixture is moistened with room temperature distilled water is applied so that the mixture is
wetted; water droplets should not be visible and placed into a 150 x 20mm falcon sterile petri
dish (falcon #1013). The prepared dish is incubated at 26°C in the dark for 12-14 days. A beaker
of water is kept in the incubator to humidify (if necessary).
2. The plate is removed from the incubator after 12-14 days. The mixture is placed within a
large kimwipe that has been folded in half over a mesh screen/sieve to create a pouch. Care is
taken to contain the mixture within the kimwipe to avoid loss of sample and potential charcoal
contamination of later steps. The kimwipe serves as a filter for the migrating larvae emerging
from the mixture.
3. Water is preheated to 37-40°C. A funnel is set up so that it hangs vertically. Tubing has been
secured to the bottom of the funnel and a clamp is in place. The kimwipe/screen/sample is
placed inside a funnel such that the diameter of the screen fits within the middle diameter of the
funnel. The preheated water is poured slowly over the top of the
sample until the surface is submerged by 1-2 cm of water and
the tubing below is full. Again, care is taken to keep the
charcoal mixture within the kimwipe as the larvae do not
survive well in dirty water. The air bubble that develops in the
tubing over the top of the clamp is “burped” to remove.
4. The funnel apparatus is left at room temperature (22°C) for
approx. 18 hours. For funnels set up with ~1000ml water--the
bottom 2 X 50 mls of water in the tubing is decanted into 2
sterile 50 ml conicals by opening the clamp slightly. The sample
is left undisturbed at room temperature on the bench for at least
an hour to allow the emerged larvae to settle to the bottom. The
top 45ml of liquid is then carefully removed and clean water is
added to the remaining 5ml. This washing step is repeated 2
times to remove any contaminated water.
5. The final remaining 5 ml containing the larvae are visually
assessed to confirm the presence of larvae. The volume is
increased with 1X BU buffer (50 mM Na2HPO4, 22 mM KH2PO4, 70 mMNaCl; pH 6.8) for
storage (10L3/µl).
10X BU Buffer= 500 mM Na2HPO4, 220 mM KH2PO4, 700 mMNaCl; pH 6.8; filter sterilize
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Appendix 4: EGG HATCH ASSAY (EHA)

Purpose: Calculate the percent hatching of individual samples in a panel of albendazole
concentrations (0, 0.1, 1, 2, and 5 µg/ml) to screen for resistant phenotypes.
Supplies:
6 - 50ml conicals for Albendazole solutions
Procedure:
 Prepare a 5 mg/ml solution of albendazole resuspended in methanol (MeOH)
 Prepare by dissolving 0.2 grams in 40 ml MeOH
*NOTE* albendazole will form a milky solution- NOT CLEAR
 Prepare a 20 µg/ml solution by adding 200 µl of 5 mg/ml solution to 50 ml H2O
 Then:
Prepare the following solutions:
0 µg/ml…………………………………….Add 200 μl of methanol to 50 ml of water
2 µg/ml……………………….……………Add 5 ml of 20 µg/ml solution to 45 ml water
4 µg/ml………………………………….…Add 10 ml of 20 µg/ml solution to 40 ml water
10 µg/ml…………………………………..Add 25 ml of 20 µg/ml solution to 25 ml water
20 µg/ml…………………………………..Use 20 µg/ml solution
 For each sample to be tested add 100 µl per well of the above solutions in duplicate to wells of
a 96 well plate.
PLATE SET UP: *NOTE*
Final concentrations to be tested reflect the dilution of
adding 100 µl of extracted hookworm eggs to the above solutions
 Add 100 µl of appropriate stock ABZ solution to each well.
 Add 100 µl (50 eggs) of the egg sample to be tested to each well.
***Final volume per well= 200 µl***
0
0
1
1
2
2
5
5
10
µg/ml µg/ml µg/ml µg/ml µg/ml µg/ml µg/ml µg/ml
µg/ml
Repl 1 Repl 2 Repl 1 Repl 2 Repl 1 Repl 2 Repl 1 Repl 2 Repl 1
0
0
1
1
2
2
5
5
10
Subject
µg/ml µg/ml µg/ml µg/ml µg/ml µg/ml µg/ml µg/ml
µg/ml
2
Repl 1 Repl 2 Repl 1 Repl 2 Repl 1 Repl 2 Repl 1 Repl 2 Repl 1
***CONFIRM THE ADDITION OF EGGS TO EACH WELL USING A
MICROSCOPE***
Subject
1

10
µg/ml
Repl 2
10
µg/ml
Repl 2

 Incubate the sample plate at 27°C for 48 hours.
 Record the number of larvae and the number of unhatched eggs for each treatment.
 Calculate % hatching as follows:
Number of larvae
(Number of unhatched eggs + Number of larvae) X 100= % hatching
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